Lucane Zane, Kursite Mirdza, Sablinskis Kristaps, Gailite Linda, Kurjane Natalja
Department of Biology and Microbiology, Riga Stradins University, LV-1007 Riga, Latvia.
Department of Public Health and Epidemiology, Riga Stradiņš University, LV-1007 Riga, Latvia.
Vaccines (Basel). 2023 Oct 25;11(11):1637. doi: 10.3390/vaccines11111637.
The European Society for Immunodeficiencies recommends that all patients with inborn errors of immunity (IEI) without contraindications should receive SARS-CoV-2 vaccination. The aim of this study was to investigate the reasons that discourage IEI patients from receiving the recommended vaccination and to assess vaccination coverage among IEI patients in Latvia.
In this multicenter mixed-methods study, the vaccination status of all patients with IEI within two tertiary centers in Latvia was reviewed using electronic health records. Semi-structured interviews were conducted with 16 IEI patients who did not undergo vaccination, and a thematic analysis was performed.
A total of 341 patients (49.3% female; median age 19.7 years (IQR:17)) were included in the quantitative part. The proportion of fully vaccinated individuals aged ≥ 12 years was 66.8%-70.9% with patients with selective IgA deficiency and 58.8% with other IEI (χ² = 14.12, < 0.001). The proportion of fully vaccinated individuals aged 5-11 years was 11.1%. Age was associated with vaccination status: younger patients were found to have a significantly lower likelihood of receiving vaccination (U = 8585, < 0.001). The five main themes identified were as follows: (1) fear and uncertainty; (2) risk and benefit assessment: COVID-19 vaccine-is it worth it? (3) external influences: the dark horse of the decision-making-people around us; (4) individuals against the system; and (5) beliefs about vaccination and COVID-19. Under-representation of certain IEI groups and recall bias are possible limitations of this study.
While most reasons for hesitancy were similar to those previously described in the general population, disease-specific concerns were also identified.
欧洲免疫缺陷学会建议,所有无禁忌证的先天性免疫缺陷(IEI)患者均应接种新冠病毒疫苗。本研究的目的是调查阻碍IEI患者接种推荐疫苗的原因,并评估拉脱维亚IEI患者的疫苗接种覆盖率。
在这项多中心混合方法研究中,利用电子健康记录对拉脱维亚两个三级中心内所有IEI患者的疫苗接种状况进行了回顾。对16名未接种疫苗的IEI患者进行了半结构化访谈,并开展了主题分析。
定量部分共纳入341例患者(女性占49.3%;中位年龄19.7岁(四分位间距:17))。≥12岁的完全接种疫苗个体比例在选择性IgA缺乏患者中为66.8%-70.9%,在其他IEI患者中为58.8%(χ² = 14.12,P < 0.001)。5-11岁的完全接种疫苗个体比例为11.1%。年龄与疫苗接种状况相关:发现较年轻患者接种疫苗的可能性显著较低(U = 8585,P < 0.001)。确定的五个主要主题如下:(1)恐惧和不确定性;(2)风险和获益评估:新冠病毒疫苗——值得接种吗?(3)外部影响:决策的黑马——我们周围的人;(4)个人与体制对抗;(5)对疫苗接种和新冠病毒的看法。某些IEI群体代表性不足和回忆偏倚可能是本研究的局限性。
虽然大多数犹豫的原因与之前在普通人群中描述的相似,但也发现了特定疾病相关的担忧。